COMPANY
Clinuvel Europe Limited
Clinuvel Europe Limited: marketing authorisation holder, trial sponsor for Afamelanotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Afamelanotide | Scenesse (EMEA/H/C/002548), Authorised Regulator EMA |
|---|
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Afamelanotide | 3 registered trials Trial register ClinicalTrials.gov |
|---|---|
| Afamelanotide | 5 registered trials Trial register EU CTIS |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.